Haier Biomedical: Repurchased 1.2809 million shares, total amount of funds used 41.76 million yuan.

Haier Bio announced on May 6th that the company held the fourth meeting of the third board of directors on January 13, 2025, and passed the proposal on the repurchase of company shares through centralized bidding trading. The company agreed to repurchase some of the RMB ordinary shares issued by the company through the Shanghai Stock Exchange stock trading system through centralized bidding trading with its own funds. The repurchased shares will be used in the future for employee stock ownership plans or equity incentives at an appropriate time. The repurchase price will not exceed 50 yuan per share, the total amount of repurchase funds will not be less than 100 million yuan, and will not exceed 200 million yuan. The repurchase period will be within 12 months from the date of approval of the repurchase plan by the company's board of directors. As of April 30, 2025, the company has repurchased a total of 1.2809 million shares, accounting for 0.4029% of the total share capital of the company. The repurchase price range is between 30.86 yuan per share and 34.69 yuan per share, with a total funding of 41.76 million yuan.